Items where Author is "Morgan, R"
|Up a level|
Morgan, R, Bryan, RT, Javed, S, Launchbury, F, Zeegers, MP, Cheng, KK, James, ND, Wallace, DM, Hurst, CD, Ward, DG, Knowles, MA and Pandha, H (2013) Expression of Engrailed-2 (EN2) protein in bladder cancer and its potential utility as a urinary diagnostic biomarker. Eur J Cancer . ISSN 0959-8049
Alharbi, RA, Pettengell, R, Pandha, HS and Morgan, R (2012) The role of HOX genes in normal hematopoiesis and acute leukemia. Leukemia . ISSN 0887-6924
Morgan, R, Boxall, A, Harrington, K, Simpson, G, Gillett, C, Michael, A and Pandha, H (2012) Targeting the HOX / PBX dimer in breast cancer Breast Cancer Research and Treatment .
Morgan, R, Boxall, A, Bhatt, A, Bailey, M, Hindley, R, Langley, S, Whitaker, HC, Neal, DE, Ismail, M, Whitaker, H, Annels, N, Michael, A and Pandha, H (2011) Engrailed-2 (EN2): A Tumor Specific Urinary Biomarker for the Early Diagnosis of Prostate Cancer CLINICAL CANCER RESEARCH, 17 (5). 1090 - 1098. ISSN 1078-0432
Heinemann, L, Simpson, GR, Boxall, A, Kottke, T, Relph, KL, Vile, R, Melcher, A, Prestwich, R, Harrington, KJ, Morgan, R and Pandha, HS (2011) Synergistic effects of oncolytic reovirus and docetaxel chemotherapy in prostate cancer. BMC Cancer, 11 . 221 - ?. ISSN 1471-2407
Morgan, R, Plowright, L, Harrington, KJ, Michael, A and Pandha, HS (2010) Targeting HOX and PBX transcription factors in ovarian cancer BMC CANCER, 10 . ? - ?. ISSN 1471-2407
Pandha, HS, Heinemann, L, Simpson, GR, Melcher, A, Prestwich, R, Errington, F, Coffey, M, Harrington, KJ and Morgan, R (2009) Synergistic Effects of Oncolytic Reovirus and Cisplatin Chemotherapy in Murine Malignant Melanoma CLINICAL CANCER RESEARCH, 15 (19). 6158 - 6166. ISSN 1078-0432
Morgan, R and Whiting, K (2008) Differential expression of HOX genes upon activation of leukocyte sub-populations INTERNATIONAL JOURNAL OF HEMATOLOGY, 87 (3). 246 - 249. ISSN 0925-5710
Morgan, R, Fairfax, B and Pandha, HS (2006) Calcium insensitivity of FA-6, a cell line derived from a pancreatic cancer associated with humoral hypercalcemia, is mediated by the significantly reduced expression of the Calcium Sensitive Receptor transduction component p38 MAPK MOLECULAR CANCER, 5 . ? - ?. ISSN 1476-4598